Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection

Applied and Environmental Microbiology

Volumn 77, Issue 14, 2011, Pages 5023-5026

  Caetano, Tânia ^a,b   Krawczyk, Joanna M ^c   Mösker, Eva ^c   Süssmuth, Roderich D ^c   Mendo, Sónia ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b Medinfar Pharmaceutical Products SA   (Portugal)

^c TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

E. COLI; IMMUNITY GENES; LANTIBIOTIC PRODUCTION; LANTIBIOTICS; MUTANT STRAIN; OUTER MEMBRANE; TWO-COMPONENT;

BIOCHEMISTRY; GENES;

ESCHERICHIA COLI;

BACTERIAL PROTEIN; BACTERIOCIN; LICHENICIDIN, BACILLUS LICHENIFORMIS;

ANTIMICROBIAL ACTIVITY; EXPERIMENTAL STUDY; FECAL COLIFORM; GENE EXPRESSION; MEMBRANE; MICROBIAL ACTIVITY; MUTATION; PEPTIDE;

ARTICLE; BACTERIAL GENE; BIOSYNTHESIS; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; METABOLISM; MUTATION; OPEN READING FRAME;

BACTERIAL PROTEINS; BACTERIOCINS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC ENGINEERING; MUTATION; OPEN READING FRAMES;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 79961089528     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00270-11     Document Type: Article

References (15)

1. Boziaris, I. S., and M. R. Adams. 2000. Transient sensitivity to nisin in cold-shocked Gram negatives. Lett. Appl. Microbiol. 31:233-237.
2. Braun, M., and T. J. Silhavy. 2002. Imp/OstA is required for cell envelope biogenesis in Escherichia coli. Mol. Microbiol. 45:1289-1302.
3. Caetano, T., J. M. Krawczyk, E. Mösker, R. D. Süssmuth, and S. Mendo. 2011. Heterologous expression, biosynthesis and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem. Biol. 18:90-100.
4. Draper, L. A., et al. 2009. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol. 71:1043-1054.
5. Draper, L. A., P. Ross, C. Hill, and P. D. Cotter. 2008. Lantibiotic immunity. Curr. Protein Pept. Sci. 9:39-49.
6. Kalchayanand, N., M. B. Hanlin, and B. Ray. 1992. Sublethal injury makes Gram-negative and resistant Gram-positive bacteria sensitive to the bacteriocins, pediocin AcH and nisin. Lett. Appl. Microbiol. 15:239-243.
7. McAuliffe, O., C. Hill, and R. P. Ross. 2000. Identification and overexpression of ltnI, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology 146:129-138.
8. Oman, T. J., and W. A. van der Donk. 2009. Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem. Biol. 4:865-874.
9. Rey, M., et al. 2004. Complete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus species. Genome Biol. 5:R77.
10. Ruiz, N., B. Falcone, D. Kahne, and T. J. Silhavy. 2005. Chemical conditionality: a genetic strategy to probe organelle assembly. Cell 121:307-317.
11. Shenkarev, Z. O., et al. 2010. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochemistry 49:6462-6472.
12. Stevens, K. A., B. W. Sheldon, N. A. Klapes, and T. R. Klaenhammer. 1991. Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria. Appl. Environ. Microbiol. 57:3613-3615.
13. Veith, B., et al. 2004. The complete genome sequence of Bacillus licheniformis DSM13, an organism with great industrial potential. J. Mol. Microbiol. Biotechnol. 7:204-211.
14. Wiedemann, I., et al. 2006. The mode of action of the lantibiotic lacticin 3147-a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol. 61:285-296.
15. Wu, T., et al. 2005. Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli. Cell 121:235-245.